OpenLegislation

Paragraph 5 Exceptions - generalI1

United Kingdom

Exceptions to the activities described in paragraph 2 are—

(a)

general services or servicing not related to core synthetic biology, where “core” means those activities without which experiments cannot be conducted, such as DNA synthesis or cloning;

(b)

the use of microorganisms to remove harmful contaminants, pollutants or toxins from the environment (known as bioremediation), including bio-based reagents that allow for testing for contaminants;

(c)

any approach used to gather clinical information for the purpose of making a clinical decision or making a diagnosis (known as diagnostics) but not the storage or ownership of sensitive human genetic information that enables the identification of an individual;

(d)

industrial biotechnology research, development or production using enzymes or organisms that have not been modified through the application of synthetic biology;

(e)

the production of substances ordinarily consumed as food or used as feed, including any ingredient or component of such substances;

(f)

gene therapy, where it is used solely for the purpose of replacing missing or defective genes to restore phenotypes to achieve a therapeutic effect;

(g)

cell therapy, where cells are modified by genetic engineering and then introduced into a patient to treat disease.

Annotations

Commencement

I1

Sch. 16 para. 5 in force at 4.1.2022, see reg. 1(2)